Published on in Vol 8 (2024)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/56553, first published
.

Journals
- Al Meslamani A, Jarab A, Mohammed E, Elrefae A. Biosimilar stewardship at the interface of disproportionality methods and AI integration: current evidence and potential strategies. Expert Opinion on Biological Therapy 2026;26(2):157 View
- Domínguez-Fernández S, Montenegro-Méndez S, González-Rodríguez M, Cano-Sanz N, Duro-Martínez A, Bella-Castillo P, Fontán-Vinagre G, Guerrero-Menéndez R. Assessing Nurses’ Knowledge and Attitudes Towards Biosimilars: Results from a National Survey. Healthcare 2026;14(4):524 View
- Duwez M, Finckh A, Bonnabry P. A pharmacist-led intervention to promote the uptake of an infliximab biosimilar by patients and physicians in a university hospital rheumatology unit. European Journal of Hospital Pharmacy 2025:ejhpharm-2025-004604 View
